Traverso Giovanni, Shuber Anthony, Olsson Louise, Levin Bernard, Johnson Constance, Hamilton Stanley R, Boynton Kevin, Kinzler Kenneth W, Vogelstein Bert
Lancet. 2002 Feb 2;359(9304):403-4. doi: 10.1016/S0140-6736(02)07591-8.
Detection of mutations in faecal DNA represents a promising, non-invasive approach for detecting colorectal cancers in average-risk populations. One of the first practical applications of this technology involves the examination of microsatellite markers in sporadic cancers with mismatch-repair deficiencies. Since such cancers nearly always occur in the proximal colon, this test might be useful as an adjunct to sigmoidoscopy, which detects only distal colorectal lesions. We report here the first in-depth analysis of faecal DNA from patients with proximal cancers to determine the feasibility, sensitivity, and specificity of this approach. Using a sensitive method for microsatellite mutation detection, we found that 18 of 46 cancers had microsatellite alterations and that identical mutations could be identified in the faecal DNA of 17 of these 18 cases.
检测粪便DNA中的突变是一种很有前景的非侵入性方法,用于在平均风险人群中检测结直肠癌。这项技术最早的实际应用之一涉及检测错配修复缺陷的散发性癌症中的微卫星标记。由于此类癌症几乎总是发生在近端结肠,该检测可能作为乙状结肠镜检查的辅助手段,后者仅能检测远端结直肠病变。我们在此报告了对近端癌症患者粪便DNA的首次深入分析,以确定该方法的可行性、敏感性和特异性。使用一种敏感的微卫星突变检测方法,我们发现46例癌症中有18例存在微卫星改变,并且在这18例中的17例患者的粪便DNA中可以鉴定出相同的突变。